Cardiovascular risks post-COVID-19 vaccination: Key findings

FHS
October 3, 2024
10:29 am

Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.

New study links shorter time to fall asleep and snoring to higher risk of ovarian decline

Sleep disturbances, including snoring, are linked to diminished ovarian reserve in women, impacting fertility and hormone levels crucial for pregnancy.

November 5, 2024

DB-1310 by Duality Biologics (Shanghai) for Non-Small Cell Lung Cancer: Likelihood of Approval

DB-1310 is under clinical development by Duality Biologics (Shanghai) and currently in Phase II for Non-Small Cell Lung Cancer.

December 7, 2023

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer – Biotech Investments

Issuer: CureVac / Key word(s): Personnel 04.11.2024 / 13:03 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Strengthens Leadership Team

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.